![[Valid Atom 1.0]](valid-atom.png "Validate my Atom 1.0 feed")
Types :
- ductal carcinoma
- lobular carcinoma
Causes :
- age :- women more than 50 years
- sex :- women are 100 times more prone than males
- family history of breast cancer and genetic influence
- hormonal replacement therapy, alcohol use
- menstrual cycle :- early menarche and late menapause
- radiation
Clinical features :
- lump in breast
- change in size, shape or feel of breast and nipple
- abnormal fluid coming from breast
- In advanced cancer :- bone pain, breast pain, skin ulcer, swelling in one arm, weight loss
Investigations :
- MRI, ultrasound of breast
- biopsy
- mammography
- PET scan
- sentinel lymph node biopsy
Treatment :
- chemotheraphy
- radiotherapy
- surgery includes
lumpectomy :- removal of breast lump
mastectomy :- removal of all or part of breast and nearby structures
- hormonal therapy ex :- tamoxifen
- ductal carcinoma
- lobular carcinoma
Causes :
- age :- women more than 50 years
- sex :- women are 100 times more prone than males
- family history of breast cancer and genetic influence
- hormonal replacement therapy, alcohol use
- menstrual cycle :- early menarche and late menapause
- radiation
Clinical features :
- lump in breast
- change in size, shape or feel of breast and nipple
- abnormal fluid coming from breast
- In advanced cancer :- bone pain, breast pain, skin ulcer, swelling in one arm, weight loss
Investigations :
- MRI, ultrasound of breast
- biopsy
- mammography
- PET scan
- sentinel lymph node biopsy
Treatment :
- chemotheraphy
- radiotherapy
- surgery includes
lumpectomy :- removal of breast lump
mastectomy :- removal of all or part of breast and nearby structures
- hormonal therapy ex :- tamoxifen
In 2012, it is estimated that among U.S. women:
ReplyDeleteThere will be 226,870 new cases of invasive breast cancer (includes new cases of primary breast cancer among survivors, but not recurrence of original breast cancer among survivors).
There will be 63,300 new cases of in situ breast cancer (includes ductal carcinoma in situ (DCIS) and lobular carcinoma in situ (LCIS), of those, about 85 percent were DCIS).